Артериальная гипертония и применение нестероидных противовоспалительных препаратов: преимущество амлодипина

1. Liebson PR, Grandits GA, Dianzumba S et al. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1995; 91: 698–706.
2. The ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA 2002; 288: 2981–97.
3. Dahlof B, Sever P, Poulter NR, ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial. Lancet 2005; 366: 895–906.
4. Pitt B, Byington RP, Furberg CDet al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation 2000; 102: 1503–10.
5. Collins R, Peto R, MacMahon S, Hebert P et al. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827–38.
6. Morgan T, Anderson A. The effect of nonsteroidal anti-inflammatory drugs on blood pressure in patients treated with different antihypertensive drugs. J Clin Hypertens 2003; 5: 53–7.
7. Johnson AC, Nguyen TV, Day RO. Do Nonsteroidal Anti-inflammatory Drugs Affect Blood Pressure? A Meta-Analysis. Ann Intern Med. 1994; 121: 289–300.
8. Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med 1993; 153: 477–84.
9. Nowak J, Wennmalm A. Influence of indomethacin and of prostaglandin E1 on total and regional blood flow in man. Acta Physiol Scand 1978; 102: 484–91.
10. Whelton A, White WB, Bello AE et al. Effects of celecoxib and rofecoxib on blood pressure and edema in patients 65 years of age with systemic hypertension and osteoarthritis. Am J Cardiol 2002; 90: 959–63.
11. Bombardier C, Laine L, Reicin A et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000; 343: 1520–8.
12. Silverstein FE, Faich G, Goldstein JL et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti- inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000; 284: 1247–55.
13. Aw DJ, Haas SJ, Liew D, Krum H. Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure. Arch Intern Med 2005; 165: 490–6.
14. Sandler DP, Burr FR, Weinberg CR. Non-steroidal anti-inflammatory drugs and the risk for chronic renal disease. Ann Intern Med 1991; 115: 165–72.
15. Blackshear JL, Davidman M, Stillman MT. Identification of risk for renal insufficiency from nonsteroidal anti-inflammatory drugs. Arch Intern Med 1983; 143: 1130–4.
16. Avanzini F, Palumbo G, Alli C et al. Effects of low dose aspirin on clinic and ambulatory blood pressure in treated hypertensive patients. Am J Hypertens 2000; 13: 611–6.
17. Morgan T, Anderson A, Wilson D et al. Paradoxical effect of sodium restriction on blood pressure in people on slow channel calcium blocking drugs. Lancet 1986; 1: 793.
18. Чазова И.Е., Ратова Л.Г. Антагонисты кальция в лечении артериальной гипертонии (исследование ЭТНА). Consilium Medicum 2005; 2: 25–7.
19. Чазова И.Е., Ратова Л.Г. Эффективность антигипертензивной терапии у больных артериальной гипертонией в зависимости от риска сердечно-сосудистых осложнений. Кардиоваскул. терапия и профилактика. 2008; 7(2): 78–82.

М.В.Ежов

ФГУ Российский кардиологический научно-производственный комплекс, НИИ кардиологии им. А.Л. Мясникова, Москва
marat_ezhov@mail.ru

________________________________________________

M.V.Yezhov
marat_ezhov@mail.ru